[ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#Head", "@graph": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#pubinfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#provenance", "@graph": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ] } ] }, { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#pubinfo", "@graph": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "UTEeHwYfV6inHkcTx2niWTf7Ohg0EvKibWcmaNMj3Ihdt6p0yT4KiP1ugQM8N7TQQjuPVFGUpRv9fQOyBuq4cQK+AFZYnqJI21Klqou6PhLmHl9MnO4AbKImtxWzY85mKAUSBk1fu/Stn3+g8MzsxUK+trpMUv65C19FOkK6OQo=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o" } ] }, { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o", "http://purl.org/dc/terms/created": [ { "@value": "2021-04-03T11:32:11.095+02:00", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://purl.org/dc/terms/creator": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [ { "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [ { "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RA64ptuigOfVGfIhpdwWeJnssaHV9jTQCnAm6Pvgrvmos" } ] } ] }, { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#assertion", "@graph": [ { "@id": "http://purl.obolibrary.org/obo/HP_0007359", "https://schema.org/possibleTreatment": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#medtherapy" } ] }, { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#medtherapy", "http://www.w3.org/ns/prov#wasDerivedFrom": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#quote" } ], "https://schema.org/drug": [ { "@id": "http://identifiers.org/drugbank/DB00776" } ], "https://schema.org/targetPopulation": [ { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#targetpop" } ], "https://w3id.org/neurodkg/indicationType": [ { "@id": "https://w3id.org/neurodkg/AdjunctiveTherapy" } ] }, { "@id": "http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#quote", "http://www.w3.org/ns/prov#value": [ { "@value": "Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures." } ], "http://www.w3.org/ns/prov#wasQuotedFrom": [ { "@id": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2515391e-3a88-4226-92e5-f641c8409fe5" } ] } ] } ]